Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Allemagne)

Index « Auteurs » - entrée « Dalil Hannani »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dalibor Sedlacek < Dalil Hannani < Dalila Pinto  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000E13 (2015) Dalil Hannani [France] ; Marie Vétizou [France] ; David Enot [France] ; Sylvie Rusakiewicz [France] ; Nathalie Chaput [France] ; David Klatzmann [France] ; Melanie Desbois [France] ; Nicolas Jacquelot [France] ; Nadège Vimond [France] ; Salem Chouaib [France] ; Christine Mateus [France] ; James P. Allison [États-Unis] ; Antoni Ribas [États-Unis] ; Jedd D. Wolchok [États-Unis] ; Jianda Yuan [États-Unis] ; Philip Wong [États-Unis] ; Michael Postow [États-Unis] ; Andrzej Mackiewicz [Pologne] ; Jacek Mackiewicz [Pologne] ; Dirk Schadendorff [Allemagne] ; Dirk Jaeger [Allemagne] ; Alan J. Korman [États-Unis] ; Keith Bahjat [États-Unis] ; Michele Maio [Italie] ; Luana Calabro [Italie] ; Michele Wl Teng [Australie] ; Mark J. Smyth [Australie] ; Alexander Eggermont [France] ; Caroline Robert [France] ; Guido Kroemer [France] ; Laurence Zitvogel [France]Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25
001080 (2014) Antonella Sistigu [Italie] ; Takahiro Yamazaki [France] ; Erika Vacchelli [France] ; Kariman Chaba [France] ; David P. Enot [France] ; Julien Adam [France] ; Ilio Vitale [Italie] ; Aicha Goubar [France] ; Elisa E. Baracco [France] ; Catarina Remédios [France] ; Laetitia Fend [France] ; Dalil Hannani [France] ; Laetitia Aymeric [France] ; Yuting Ma [France] ; Mireia Niso-Santano [France] ; Oliver Kepp [France] ; Joachim L. Schultze [Allemagne] ; Thomas Tüting [Allemagne] ; Filippo Belardelli [Italie] ; Laura Bracci [Italie] ; Valentina La Sorsa [Italie] ; Giovanna Ziccheddu [Italie] ; Paola Sestili [Italie] ; Francesca Urbani [Italie] ; Mauro Delorenzi [Suisse] ; Magali Lacroix-Triki [France] ; Virginie Quidville [France] ; Rosa Conforti [France] ; Jean-Philippe Spano [France] ; Lajos Pusztai [États-Unis] ; Vichnou Poirier-Colame [France] ; Suzette Delaloge [France] ; Frederique Penault-Llorca [France] ; Sylvain Ladoire [France] ; Laurent Arnould [France] ; Joanna Cyrta [France] ; Marie-Charlotte Dessoliers [France] ; Alexander Eggermont [France] ; Marco E. Bianchi [Italie] ; Mikael Pittet [États-Unis] ; Camilla Engblom [États-Unis] ; Christina Pfirschke [États-Unis] ; Xavier Préville [France] ; Gilles Uzè [France] ; Robert D. Schreiber [États-Unis] ; Melvyn T. Chow [Australie] ; Mark J. Smyth [Australie] ; Enrico Proietti [Italie] ; Fabrice André [France] ; Guido Kroemer [France] ; Laurence Zitvogel [France]Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.
001081 (2014) Yuting Ma [Allemagne] ; Stephen R. Mattarollo ; Sandy Adjemian ; Heng Yang ; Laetitia Aymeric ; Dalil Hannani ; João Paulo Portela Catani ; Helene Duret ; Michele W L. Teng ; Oliver Kepp ; Yidan Wang ; Antonella Sistigu ; Joachim L. Schultze ; Gautier Stoll ; Lorenzo Galluzzi ; Laurence Zitvogel ; Mark J. Smyth ; Guido KroemerCCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy.
001239 (2014) YUTING MA [France] ; Stephen R. Mattarollo [Australie] ; Sandy Adjemian [France] ; HENG YANG [France] ; Laetitia Aymeric [France] ; Dalil Hannani [France] ; João Paulo Portela Catani [France, Brésil] ; Helene Duret [Australie] ; Michele W. L. Teng [Australie] ; Oliver Kepp [France] ; YIDAN WANG [France] ; Antonella Sistigu [France] ; Joachim L. Schultze [Allemagne] ; Gautier Stoll [France] ; Lorenzo Galluzzi [France] ; Laurence Zitvogel [France] ; Mark J. Smyth [Australie] ; Guido Kroemer [France]CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy

List of associated KwdEn.i

Nombre de
documents
Descripteur
3Animals
3Female
3Mice, Inbred C57BL
2Anthracyclines (therapeutic use)
2Humans
2Mice
1Accessory cell
1Adaptor Proteins, Vesicular Transport (metabolism)
1Adolescent
1Adult
1Aged
1Aged, 80 and over
1Anthracyclines (pharmacology)
1Antibodies, Monoclonal (pharmacology)
1Antibodies, Monoclonal (therapeutic use)
1Antigen Presentation
1Antigen presenting cell
1Antigen-Presenting Cells (drug effects)
1Antigen-Presenting Cells (immunology)
1Antigens, Neoplasm (metabolism)
1Antineoplastic Agents (therapeutic use)
1Breast Neoplasms (drug therapy)
1Breast Neoplasms (genetics)
1Breast Neoplasms (immunology)
1Breast Neoplasms (pathology)
1CC chemokine
1CC-chemokine ligand 2
1CCR2 chemokine receptor
1CD4-Positive T-Lymphocytes (immunology)
1CD4-Positive T-Lymphocytes (metabolism)
1CTLA-4 Antigen (immunology)
1CTLA-4 Antigen (metabolism)
1Cell Line, Tumor
1Chemokine CCL2 (genetics)
1Chemokine CCL2 (metabolism)
1Chemokine CXCL10 (metabolism)
1Chemokine receptor
1Chemotherapy
1Cohort Studies
1Dendritic Cells (cytology)
1Disease Models, Animal
1Doxorubicin (pharmacology)
1Doxorubicin (therapeutic use)
1Flow Cytometry
1Gene Expression Regulation, Neoplastic (drug effects)
1Immunocompetence (drug effects)
1Immunotherapy
1Interferon Type I (biosynthesis)
1Interferon Type I (metabolism)
1Interleukin-2 Receptor alpha Subunit (blood)
1Interleukin-2 Receptor alpha Subunit (immunology)
1Lymph Node Excision
1Lymphocyte Activation
1Male
1Malignant tumor
1Melanoma (mortality)
1Melanoma (pathology)
1Melanoma (therapy)
1Mice, Transgenic
1Microscopy, Fluorescence
1Middle Aged
1Monocyte chemoattractant protein 1
1Myxovirus Resistance Proteins (metabolism)
1Neoadjuvant Therapy
1Neoplasm Metastasis
1Neoplasm Transplantation
1Neoplasms (drug therapy)
1Oligonucleotide Array Sequence Analysis
1RNA (metabolism)
1RNA, Messenger (genetics)
1RNA, Messenger (metabolism)
1Receptor, Interferon alpha-beta (metabolism)
1Receptors, CCR2 (metabolism)
1Receptors, Interleukin-2 (genetics)
1Receptors, Interleukin-2 (immunology)
1Receptors, Interleukin-2 (metabolism)
1Receptors, Pattern Recognition (metabolism)
1Recombinant Proteins (biosynthesis)
1Recombinant Proteins (genetics)
1Recombinant Proteins (pharmacology)
1Recruitment
1Signal Transduction
1Signal Transduction (drug effects)
1T-Lymphocytes (cytology)
1T-Lymphocytes, Regulatory (immunology)
1Toll-Like Receptor 3 (metabolism)
1Treatment Outcome
1Up-Regulation (drug effects)
1Young Adult

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "Dalil Hannani" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i  \
                -Sk "Dalil Hannani" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Allemagne
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Dalil Hannani
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024